The Genomic Data Commons, the MMRF, and the Project GENIE are all inking new arrangements around sharing genomics data and crowdsourcing analysis.
The multi-center precision medicine trial has matched approximately 700 patients to 24 treatment arms so far, but some arms appear to be falling short of their recruitment goal.
Researcher Amanda Paulovich will develop multiple-reaction monitoring mass spectrometry assays and apply them to samples from cancer patients in the program.
The partners will use Protagen’s autoantibody measuring technology to identify biomarkers of patient response to cancer immunotherapies.
The research used multiple genetic analyses on samples collected over 29 years to show changes associated with disease progression.
Grade 3 breast tumors generally have worse prognoses, but SEER data showed that Oncotype DX can identify a large proportion of patients who do well without chemo.
Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.
The collaborators aim to build an artificial intelligence network that will support Vice President Joe Biden's Cancer Moonshot initiative.
The company will expand its Cancer Genomics Cloud Pilot to include additional data sources such as the NCI's Genomic Data Commons, and improve its usability.
The company is working with the University of Florida Health Cancer Center to validate its RadTox QuantiDNA test as a monitor of cfDNA in patient plasma.
Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.
An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.
The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.
In Nature this week: genotypes linked to hip osteoarthritis, and more.